P2X3antagonist34 (BLU-5937) is a potent, selective, and orally active antagonist of P2X3 homotrimeric receptors, exhibiting strong antitussive (cough-suppressing) effects. It significantly and dose-dependently reduces histamine-induced enhancement of citric acid-evoked coughs in a guinea pig cough model. Additionally, it effectively and dose-dependently attenuates ATP-induced potentiation of citric acid-evoked coughs in guinea pigs.